相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The N2N3 domains of CIfA, FnbpA and FnbpB in Staphylococcus aureus bind to human complement factor H, and their antibodies enhance the bactericidal capability of human blood
Xinrui Mao et al.
JOURNAL OF BIOCHEMISTRY (2021)
Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms
Lloyd S. Miller et al.
FEMS MICROBIOLOGY REVIEWS (2020)
Identification of a domain critical for Staphylococcus aureus LukED receptor targeting and lysis of erythrocytes
Marilyn T. Vasquez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers
Zoltan Magyarics et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In Staphylococcus aureus, the Particulate State of the Cell Envelope Is Required for the Efficient Induction of Host Defense Responses
ByungHyun Kim et al.
INFECTION AND IMMUNITY (2019)
Preventing lung pathology and mortality in rabbit Staphylococcus aureus pneumonia models with cytotoxin-neutralizing monoclonal IgGs penetrating the epithelial lining fluid
Lukas Stulik et al.
SCIENTIFIC REPORTS (2019)
Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial
Bruno Francois et al.
INTENSIVE CARE MEDICINE (2018)
Characterisation of anti-alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against Staphylococcus aureus alpha toxin
Alexey Ruzin et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2018)
Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults
Xiang-Qing Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Safety and immunogenicity of a recombinant Staphylococcus aureus -toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults
Michael L. Landrum et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors
Andras N. Spaan et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity
E. Sachiko Seilie et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Evaluation of Platelet-Rich Plasma and Neutrophil Antimicrobial Extract as Two Autologous Blood-Derived Agents
Tomasz Szponder et al.
TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2017)
Evaluation of Platelet-Rich Plasma and Neutrophil Antimicrobial Extract as Two Autologous Blood-Derived Agents
Tomasz Szponder et al.
TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2017)
Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis
Richard Kwizera et al.
BMC MICROBIOLOGY (2017)
Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin
Binh An Diep et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies
Adriana Badarau et al.
MABS (2016)
Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes
Andras N. Spaan et al.
CELL HOST & MICROBE (2015)
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
Steven Y. C. Tong et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence
Pauline Yoong et al.
NATURE COMMUNICATIONS (2015)
Five birds, one stone: Neutralization of alpha-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody
Harald Rouha et al.
MABS (2015)
Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs
Rajan P. Adhikari et al.
PLOS ONE (2015)
Identification of a Crucial Residue Required for Staphylococcus aureus LukAB Cytotoxicity and Receptor Recognition
Ashley L. DuMont et al.
INFECTION AND IMMUNITY (2014)
Mechanisms of Neutralization of a Human Anti-α-toxin Antibody
Vaheh Oganesyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Residues Essential for Panton-Valentine Leukocidin S Component Binding to Its Cell Receptor Suggest Both Plasticity and Adaptability in Its Interaction Surface
Benoit-Joseph Laventie et al.
PLOS ONE (2014)
Separately or Combined, LukG/LukH Is Functionally Unique Compared to Other Staphylococcal Bicomponent Leukotoxins
Machi Yanai et al.
PLOS ONE (2014)
The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors
Andras N. Spaan et al.
CELL HOST & MICROBE (2013)
Evaluation of Genetically Inactivated Alpha Toxin for Protection in Multiple Mouse Models of Staphylococcus aureus Infection
Rebecca A. Brady et al.
PLOS ONE (2013)
Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue
Bryan J. Berube et al.
TOXINS (2013)
Alpha-Toxin Induces Programmed Cell Death of Human T cells, B cells, and Monocytes during USA300 Infection
Tyler K. Nygaard et al.
PLOS ONE (2012)
Enzymatic assembly of DNA molecules up to several hundred kilobases
Daniel G. Gibson et al.
NATURE METHODS (2009)
Staphylococcus aureus α-Hemolysin Activates the NLRP3-Inflammasome in Human and Mouse Monocytic Cells
Robin R. Craven et al.
PLOS ONE (2009)
Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: Structures, pore-forming mechanism, and organization of the genes
J Kaneko et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2004)
分享论文
